NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Brett H. Mueller II, DO, PhD, discusses how ArcScan has changed the way he sizes ICLs (STAAR Surgical) in clinical practice.
Author: Healio ophthalmology
Endpoint achieved in phase 2 trial of OTX-DED for short-term dry eye disease treatment
OTX-DED met the primary endpoint in a phase 2 trial investigating the ophthalmic insert for safety and efficacy in the short-term treatment of dry eye disease, according to a press release from Ocular Therapeutix.In the randomized, double-masked, vehic…
VIDEO: Anterior capsule marking improves residual astigmatism
NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Dee Stephenson, MD, discusses her research investigating the use of femtosecond lasers to align toric IOLs and reduce residual astigmatism.
VIDEO: Allergan official discusses Vuity, business acquisitions
NEW ORLEANS —In this Healio Video Perspective from the Eyecelerator meeting, Jag Dosanjh, senior vice president of U.S. eye care for Allergan, discusses activity within the company.Dosanjh touches on recent acquisitions and the FDA approval of Vuity (p…
Novel intraocular ring enhances IOL stability, prevents PCO
A novel intraocular ring provides good centration and stable holding of IOLs in the capsular bag, while effectively preventing posterior capsule opacification.“It also provides a stable environment for any future IOL replacement,” Ioannis Pallikaris, M…
Yelp ratings of medical facilities may reveal local health inequities
Counties with essential health care facilities that had lower ratings on Yelp also had higher mortality rates, data showed.“Patient experience and satisfaction with health care are increasingly recognized as important measures of health care quality, b…
VIDEO: Surgeon explains benefits of ECP to treat glaucoma
NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Philip Bloom, MD, discusses the role of endoscopic cyclophotocoagulation in the surgical management of glaucoma.
VIDEO: Susvimo provides predictable ranibizumab release, successful outcomes
NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Jay Stewart, MD, discusses his presentation on the Port Delivery System with ranibizumab, now called Susvimo (Genentech), including efficacy and safety study outcomes.
Rayner Surgical to acquire Omidria in deal valued at more than $1 billion
Omeros will sell Omidria to Rayner Surgical Group Limited in a transaction valued at more than $1 billion, according to a press release from Omeros.The transaction is expected to be finalized on or before Dec. 31 and includes an upfront payment of $125…
What IOLs do you most commonly implant during an exchange?
Click here to read the Cover Story, “IOL exchange all about setting patient expectations, determining plan of action.”The question needs to be qualified a little bit to explain why we are doing the IOL exchange in the first place.At our practice, we ha…
The weighted sum method: A powerful, practical, simple decision-making tool
“The essence of strategy is choosing what not to do.” – Michael Porter“Humans do have a knack of choosing precisely those things that are worst for them.” – J.K. RowlingAs an eye surgeon, you are a highly trained decision-maker. Although most of your t…
Surgical skills, informed consent required for IOL exchange
IOL exchange remains an important surgical procedure for the consultative ophthalmologist.In the 1980s and 1990s, gathering information from multiple sources and meetings, as many as 2% of IOLs implanted required removal and replacement. This was drive…
Rookie mistakes: Avoid the premium IOL learning curve
The time for premium IOLs has finally arrived, with many new and exciting options and fewer side effects than earlier-generation technology.Setting expectations is the most important preoperative consideration with these lenses when talking with prospe…
Presbyopia-correcting drops may benefit some pseudophakic patients
As presbyopia-correcting drops from different companies go through clinical trials and receive U.S. marketing approval, there is excitement about what these drops could mean for middle-aged presbyopes who dislike reading glasses.But there are at least …
Nystagmus, diplopia seen in 11-year-old boy
An 11-year-old boy presented to the University of New Mexico Hospital with 6 weeks of vomiting and food intolerance as well as a 13-pound weight loss over that same period.At the onset of these symptoms, he went to an outside hospital and was discharge…
LLL campaign assists in remote screening of ocular surface squamous neoplasia
The ocular surface extends from the conjunctiva to the cornea, including the fornices and the inner surfaces of the lids.The conjunctival mucosa is the predominant anatomical structure seen wrapping the entire ocular surface. The limbus and the cornea …
IOL exchange all about setting patient expectations, determining plan of action
With modern calculations and state-of-the-art lenses, IOL exchange is not regularly needed.According to Healio/OSN Section Editor Uday Devgan, MD, it is downright rare, at least in his practice.“For at least 99% or more of patients who have had surgery…
Post hoc analysis finds NCX 4251 may be effective in some patients with dry eye
NCX 4251 may be effective at reducing dry eye disease symptoms in a specific subgroup of patients, according to a press release from Nicox.NCX 4251(fluticasone propionate ophthalmic suspension 0.1%) failed to meet primary or secondary efficacy endpoint…
Uplizna effective in patients with NMOSD previously treated with rituximab
Uplizna appeared to benefit patients with neuromyelitis optica spectrum disorder who were previously treated with rituximab, according to study results published in Multiple Sclerosis and Related Disorders.“Rituximab is an anti-CD20 B-cell-depleting ag…
VIDEO: 90% of patients in clinical trial adhere to teprotumumab
NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Raymond Douglas, MD, PhD, discusses results of a clinical trial examining adherence to teprotumumab and reasons for nonadherence in patients with thyroid eye disease.